There is no consensus between authors on the definition of a replete or deficient vitamin D state. Our aim was to describe a suitable method that could be used to compare vitamin D data in subject groups with small or large numbers.
Introduction
The diverse role of vitamin D is widely recognized, particularly after discovery of its steroid structure. Vitamin D participates in mineral homeostasis, regulation of gene expression and cell differentiation. There is significant epidemiological, in vitro and animal experimental work to suggest that vitamin D deficiency is linked to several clinical conditions (Newmark 1994 , Keen et al. 1997 , Ahonen et al. 2000 , Cantorna 2000 , Hayes 2000 , Tokuda et al. 2000 , Altschuler 2001 , Ayesha et al. 2001 . 25,hydroxyvitamin D (25,OHD 3 ) deficiency has been implicated as a risk factor in syndrome X, diabetes (Boucher 1998 ) and ischaemic heart disease. Recently McGrath (2001) has proposed that the early origins of these adult problems could arise due to deficiency of vitamin D during 'a critical window of development' in prenatal and perinatal life. For example, during foetal and infant life vitamin D is essential for the central nervous system (Brunvand et al. 1996) . Thus, vitamin D deficiency during foetal development may cause early imprinting of the functional characteristics of various tissues throughout the body. The impact of this suggests that there is an avoidable risk factor for adult diseases.
Monitoring for vitamin D deficiency, however, still presents a dilemma as no consensus exists between authors worldwide on the definition or biochemical criteria of a vitamin D 'deficiency state'. Cited lower limits based on serum levels of 25,OHD 3 range between 2 and 18 ng/ml (5-45 nmol/l) (O'Shea & Carter 1998) ; 25,OHD 3 in winter ,8 ng/ml (20 nmol/l) and summer ,10 ng/ml (25 nmol/l) (Bender 1992) ; or toward levels that will minimize serum parathyroid hormone (PTH) concentrations, i.e. between 20 and 32 ng/ml (50-80 nmol/l) (Vieth 2001) .
The criteria for replete or insufficient vitamin D would also depend on the clinical impact, and both the level and duration of persistently low 25,OHD 3 complicate this. For example, although levels of 25,OHD 3 ,8 ng/ml (20 nmol/l) are known to cause clinical symptoms, such low levels will have already been in existence for many months if searching for hypovitaminosis D myopathy (Glerup et al. 2000) . 25,OHD 3 levels maintained just below 20 ng/ml (50 nmol/l) can still affect later bone mass (Docio et al. 1998) . Furthermore, serum PTH measurements can reliably be measured within the normal range only when 25,OHD 3 levels exceed 40 ng/ml (100 nmol/l) (Brot et al. 2001) .
The ongoing pathophysiological dilemma of defining deficient vitamin D levels is further complicated when comparing different subject groups. Serum 25,OHD 3 concentrations are generally measured and compared between small numbers of subjects (usually under 100), with variable characteristics (age, sex, ethnic group, diet, latitude) and are influenced by season. Previously most authors have compared subjects' vitamin D status using mean or median, S.D. and range. However, standard summary statistics utilize parametric methods and assume a normal distribution of measurements, but serum vitamin D levels may often appear as skewed or clustered data. The upper and lower limits are thus less reliably defined. A distribution method allows a visual and graphical display of data enabling comparison of differences in vitamin D throughout the whole data array. This may facilitate clinicians quickly observing relevant patterns between subject groups. (See Appendix for terminology and comparison of statistical methods.)
We illustrate the subject of 25, OHD 3 levels in different ethnic populations (asymptomatic adults) in Birmingham, UK, assayed at different times of year.
We report the use of a suitable method of comparing serum 25,OHD 3 levels with discussion of the criteria to define deficiency and normal limits appropriate for some populations.
Materials and Methods
The method of 'distributional analysis' is well known and has been used to analyse other hormone data (Matthews et al. 1991) .
The local research ethics committee approved the proposed investigation for vitamin D data. Briefly, during a 2 year period (1994) (1995) (1996) , 240 adults (median age 50 years, range 17-98; only four subjects were above the age of 75 years) attending for a single-consultation outpatient clinic at a hospital (City Hospital) in Birmingham, with symptoms unrelated to vitamin D status, were included in the study. All were having single-sample blood taken for clinical purposes additional to assay for 25,OHD 3 levels.
These subjects were non-pregnant asymptomatic adults with normal biochemistry (i.e. normal calcium, phosphate, alkaline phosphatase, renal and liver function).
Subjects were selected purposively ('convenience sample') with stratification to ensure that 30 subjects of each gender and ethnic origin (Asian or non-Asian (AfroCaribbean and Caucasian)) were included at each of two time-points ('winter' -February/March, and 'summer' -July/August). No subject was included in both seasons. Subject samples were taken over a 2 year period and dated, as such cross-sectional data were obtained from 240 subjects.
Assays
The serum samples were initially centrifuged and stored at 20 C. Irrespective of season-defined months, samples were analysed in batches within 6 months of sample drawing during the regular Regional Laboratory activity for vitamin D assay needed for clinical purposes (approximately two monthly). The serum 25,OHD 3 was initially analysed by three assays but only the results of the Incstar RIA kit are reported. The Incstar RIA ( 125 I) kit was obtained from Sorin diagnostics (now known as DiaSorin Medical Systems Group, Saluggia, Italy). This has the advantage of a specific 25,OHD 3 tracer (although it can accurately measure either D 2 or D 3 ), excellent specificity and is standardized against HPLC purified 25 OHD 3 .
Standard methods to ensure quality control of all specimens were observed (Hollis et al. 1993 , Bates 1997 . Each laboratory run contained labelled coated tubes in duplicate for each standard (total six standards 0-100 ng/ml), control and sample, and a standard curve was prepared for each run.
Specificity Specificity, by estimating the percentage of cross-reaction (50% inhibition for 25,OHD 3 ) was 100%; 25 OHD 2 was 0·6%.
Sensitivity Sensitivity analysis suggests that the lowest detectable limit distinguished from the zero standard was 0·6 ng/ml. Intra-assay variation Within-run variation was determined by replicate determination of two different control sera in one assay: variability coefficient of variation (CV) at 8·6 and 22·7 ng/ml was 9·4 and 8·2% respectively.
Inter-assay variation Between-run variation was determined by replicate measurement of two different control sera in several different assays: variability CV (%) at 33 and 49 ng/ml was 9·1 and 11% respectively.
Accuracy
The linearity was checked by serial dilution of two samples of different 25,OHD 3 concentrations with zero standard solution. Six dilutions (neat to 1:64) were performed for each sample and the diluted samples assayed by the RIA method.
Recovery Normal human serum with known concentration of 25,OHD 3 was enriched ('spiked') with four increasing amounts of 25,OHD 3 (0 to 60 ng/ml) and recovery was between 97·8 and 114%.
External quality control In our laboratory the results of the 25,OHD 3 assay method were consistently within 1 S.D. of the method group mean in the international External Quality Assessment Scheme for this metabolite.
Data analysis
The serum 25,OHD 3 data were first log-transformed for analysis by both parametric and distribution analysis methods. Mathematical transformation does not alter the relationship between each of the original data points, but allows a smoother way of identifying a pattern. Such mathematical transformation is very useful, although not an essential prerequisite when performing distribution analysis. Non-transformed data can be used by most standard methods for large sample sizes (.100 per group).
Distribution analysis Class intervals
Grouped ranges for the log 10 25,OHD 3 values (Table 1) , were generated from all the data, and subsets were then compared using the cumulative distributions across the class intervals.
Groups can be constructed with equal class intervals or equal numbers of observations. The class intervals must be both mutually exclusive and exhaustive. The group intervals do not always have to be equal, but the same intervals should be used for all the datasets to be compared.
Frequency distribution or 'domains'
Cumulative frequency distributions were obtained to provide contrasts by gender, ethnicity and season.
Frequency polygon or 'ogive' Calculation of frequency (absolute, relative or cumulative) can be made by hand or by software. Frequency distributions show how many observations on a given variable have a particular attribute. Converting these raw numbers into percentages provides a more useful description of the data. The frequency distribution is a prerequisite for both the various graphs used to display data and the basic statistics to describe a dataset. A frequency polygon (line plot) graph of the cumulative frequency enables characteristics to be easily compared (Kenney & Keeping 1962) .
Linear probit transformation
The relationship between variables x and y is often 'S' shaped as demonstrated in the cumulative frequency ogive. If the true underlying variable we are predicting is continuous, we can assume the errors are normally distributed and the probit transformation can be used.
Practically, the cumulative distributions of 25,OHD 3 data may either be plotted manually on probability paper or probit values obtained from transform tables (Fisher & Yates 1967) . The points used for the x-value of the plot are the mid-group values of the grouped 'cumulative data' from which it is easy to estimate any particular percentile of interest for any subset; and the mid-points of each class interval can be used as points in a regression equation. This provides a statistical method in assessing observed concentration (OC) differences.
The S.D. of the observations can be estimated from the slope of the probit by S.D. =covariance(x.y)/slope and differences between the lines can be assessed using the method proposed by Schefler (1969) .
To calculate a 95% confidence interval for the slope (linear probit) we simply calculated the S.E. of the slope as the equation of the sample regression line is y=a+bx and the coefficient of the variable x is b (the slope). The 95% confidence limits were calculated by the method of Snedecor & Cochran (1989) . For each vitamin D level at specified OC parameters, we followed the general form for a confidence interval point estimate (critical value) (S.E. of the estimate). Here the point estimate in question is b and its S.E. is given the critical value 2·306 for a 95% confidence interval.
For linear probits, both intercept and slope require careful interpretation. First, the intercept per se has little meaning, but horizontal differences between cumulative curves can be used to illustrate differences between estimated percentile points of different subgroups. The assessment as to whether these differences are significant can be made statistically using conventional methods, or clinically, whenever it is a matter of judgement. Secondly, differences between slopes correspond to differences between the S.D.s (more generally, variability) of the various subsets, with a steeper slope representing a smaller S.D. The advantage of this method is that the whole of the data can be compared between groups and the populations compared at any point.
Results
Of the 120 samples collected from each season, 60 were from Asian subjects and 60 from non-Asian subjects, in each case 30 males and 30 females. The results of standard summary statistics of the vitamin D data are compared within each subgroup with the OC parameters of distribution analysis (Table 2A and B) .
Cumulative frequency profile
The performance of this method is illustrated by our 25,OHD 3 concentrations and compares season, ethnicity and gender. Any given OC parameters can be estimated easily from the cumulative distribution. Figure 1 demonstrates that clear differences in concentration frequency exist throughout the whole range of 25,OHD 3 measurements.
Effect of ethnic group and season
When comparing OC 50 or lower (OC 25 ) or upper (OC 75 ) levels of 25,OHD 3 levels in ethnic groups, the difference is particularly marked in winter.
Asian 25,OHD 3 levels were significantly lower than non-Asians (P,0·05) (Table 2A) . In both seasons, over 95% of Asian men and women have a 25,OHD 3 level below the mid-point (OC 50 ) of their respective sexmatched non-Asian group (Asians vs non-Asian, winter 4·5 vs 17·2, summer 11·2 vs 19·7 ng/ml). The upper level (OC 75 ) was less than half the level seen in non-Asians (Asians vs non-Asian, winter 12·1 vs 26·7, summer 14·9 vs 32 ng/ml).
The lower level (OC 25 ) showed a 6-fold difference between Asians and non-Asians in winter and 2-fold difference in summer (Asians vs non-Asian, winter 2·3 vs 13·4, summer 7·4 vs 13·4 ng/ml).
Probability transformation analysis confirms a significant difference between Asians and non-Asians (P,0·0025) during both seasons (Fig. 2) . Effect of gender Generally, although Asian women were noted to have the lowest 25,OHD 3 levels in both seasons (Table 2A) , the OC 50 was not statistically different between sexes in either ethnic group (both seasons, female vs male: Asian 7·3 vs 8·3; non-Asian 18·0 vs 18·9 ng/ml). Interestingly, during winter, Asians of both sexes had extremely low OC 25 25,OHD 3 levels (male vs female 2·1 vs 2·5 ng/ml).
Figure 1
Performance: cumulative distribution of serum 25,OHD 3 levels. The cumulative distribution is a sigmoid curve. These ogives demonstrate visually the differences in serum 25,OHD 3 concentration frequency between two groups: comparing season, sex and ethnic group. An approximate estimate of mid-point and or any comparative parameter is described as 'observed concentrations' (OC parameters) and can be easily made visually from such plots. We propose that OC 25 level for non-Asians is used as a screening tool to detect vitamin D deficiency. Thus, a vitamin D level of 13·8 ng/ml (both seasons, both sexes) is the cut-off level for our subjects. The CV of the assay at 13·8 ng/ml is 9·4%, thus subjects with a vitamin D level of 15·1 ng/ml would be missed (false negative) and subjects with level of 12·5 ng/ml may not be deficient (false positive).
OC 25 as predictor of deficiency of vitamin D (
Using the non-Asian OC 25 , the sensitivity (the fraction of those with vitamin D deficiency correctly identified) for both groups was 93·8%, the specificity (the fraction of those without vitamin D correctly identified) was 92·8%. For the OC 25 test, the specificity of 92·8% means that 7·2% of subjects who are deficient will test falsely negative (7 of every 100 persons).
The predictive value (PV) depends on both the accuracy of the biochemical test and the prevalence of deficient subjects. As the prevalence is 80% in Asians and 17·5% in non-Asians, with the same test (OC 25 ) the PV changes.
If we test each group of 100 persons by using a test with 92·8% specificity, approximately seven persons in each group will have a false-positive test result.
Non-Asian group
The assumed vitamin D deficiency prevalence is 17·5%. Thus, 17·5 true-positive and 7 false-positive test results indicate a PV positive of 71·4% (Table 3) .
Asian group
The assumed vitamin D prevalence is 80%. With 80 true-positive tests results and 7 false-positive tests results, the PV positive is 92%.
Thus, the PV of the OC 25 level is very accurate for Asians due to the higher prevalence of vitamin D deficiency.
As the likelihood ratio equals 13, it suggests that a subject with a vitamin D level at non-Asian OC 25 is 13 times more likely to be deficient than a subject with vitamin D level above OC 25 . We conclude that the OC 25 level for non-Asians is an appropriate tool to identify vitamin D deficiency.
Normal range and deficiency
25,OHD 3 deficiency depends on season, sex and ethnic group. We could define the 25,OHD 3 deficiency as either the level of 25,OHD 3 below OC 50 or that below OC 25 for the 'standard population' in each season. The distribution method facilitates a measure of the normal range and defines a 'deficiency' appropriate to the population studied. Any OC parameter can thus be used to compare populations residing at different latitudes.
From our data, the acceptable 25,OHD 3 levels for our adult group: non-Asians OC 50 (OC 25 OC 75 ) is: winter, males 17·4 (14·1-28·2) ng/ml, females 17 (12·6-25·1) ng/ml; summer, males 20·4 (14·5-32·4) ng/ml, females 19·1 (12·3-31·6) ng/ml.
In our population, the definition of 25,OHD 3 deficiency chosen as the OC 25 parameter for both sexes, suggests that deficient levels would be <13·4 ng/ml in both seasons. These criteria suggest that 82% of Asians of both sexes have 25,OHD 3 levels below the OC 25 of the normal sex-matched population during summer and 94% of Asians are extremely 25,OHD 3 deficient during winter.
Discussion
The reported prevalence of 25,OHD 3 deficiency varies widely. In the UK, 25,OHD 3 deficiency has been reported in Asians: over 50% in community-resident elderly (Solanki et al. 1995) ; 78% attending a rheumatology clinic (Serhan et al. 1999 ) and 56% in pregnant Asian women (Alfaham et al. 1995) . We have noted an increased number of Asian infants with hypocalcaemic symptoms (Pal & Shaw 2001) . Worldwide, even in abundant sunshine, reports suggest up to 80% of dark-skinned pregnant women in Melbourne exist with subclinical hypovitaminosis D (Grover & Morley 2001 . In New Zealand, significant numbers of young Asian children (3-36 months, median age 12 months) are presenting with extremely low levels of 25,OHD 3 (Blok et al. 2000) , and a resurgence of rickets has also been seen in the USA (Rowe 2001 , Nesby-O'Dell et al. 2002 . The difference in prevalence reported between studies may relate to differences in assays used for 25,OHD 3 , the definition of 25,OHD 3 deficiency, latitude or other characteristics of the group being studied. Monitoring of 25,OHD 3 levels in subjects can only be advocated after clarification of a nationally or internationally agreed 'deficient range' for 25,OHD 3 and the optimum time to screen within the seasonal fluctuations seen over the year. Some authors suggest using a physiological definition of 25,OHD 3 deficiency (Finkelstein & Thomas 1998 ) but others exercise caution in the interpretation of these biochemical alterations (Brot et al. 2001 , Rucker et al. 2002 .
The distribution method that we propose is a simple way of identifying differences of vitamin D data between subjects. The use of 'observed concentrations' allows the use of any domain (e.g. OC 5 , OC 25 , OC 50 , OC 75 , OC 95 ) to be used for comparison by other reporters. The OC measurements reflect the probability that serum 25,OHD 3 is below a particular level. The distribution percentage enables a display of data (either as 'domain profiles' or as 'sigmoid ogives'). The purpose of graphing is to illustrate, make comparisons easy, avoid distortion and provoke thought about the data.
Cumulative frequency also facilitates conversion into linear probits enabling the differences between groups to be assessed by regression methods (Fox 1997) and confidence intervals. The use of the probit regression model in our example can be justified by positing a random, normally distributed noise process that interferes with the vitamin D pure data by imposing characteristics such as sunlight, season and latitude on the final result. These parameters could equally be considered as a weight function. For simplicity, we have separated these characteristics to describe our data. This method is easy to perform for clinicians, either with or without computer programs and facilitates comparison of vitamin D data between researchers. Table 2A and B compare the group summary values (standard vs distribution methods). Defining the percentage occupancy of the 'observed concentration' of 25,OHD 3 at OC 25 as predicting '25,OHD 3 deficiency' enables a comparison of characteristics between subjects in six groups (sample size: total 240, each group of 30). At larger sample sizes (such as during population studies under field conditions, e.g. over 100 per group), other parameters (e.g. OC 5 ) could be chosen to predict deficiency.
When using standard summary statistics, the central values such as median, mean and OC 50 are similar (Table 2B) ).
There may be several reasons for this. Although standard statistics are commonly used to summarize data and confirm statistically significant differences between groups, there are often assumptions about the distribution of data. Vitamin D is likely to be geometrically distributed and may be further skewed with small numbers of subjects or if a particular subgroup characteristic exists.
Although the central limit theorem states that as the sample size becomes large, then the sampling distribution of the mean becomes approximately normal regardless of the distribution of the original variable, with smaller sample sizes inaccuracies arise if such normality assumptions are made. Other complex methods could be used to identify the best value for the shape parameter for a range of distributions, but it is simpler to describe the dataset by a distribution method. Frequency distributions can be used to explore each variable in a dataset separately without assumption of its distribution. It looks at the range of values, the central tendency of the values and describes the pattern of response to the variable or describes each variable on its own. The disadvantage is that frequency distribution may not reveal the extreme skew in a dataset, and may de-emphasize the range or extreme values when open classes are used (e.g. over 60 or under 10). The method allows the information from several individuals to be pooled so that analysis of data from groups of individuals with a particular condition or characteristic can be made.
Differences between Asian and non-Asian groups are known to exist (Iqbal et al. 1994) . We found that in our indigenous non-pregnant adult population a state of subclinical 25,OHD 3 deficiency exists in a substantially high percentage of an asymptomatic Asian population (winter 94%, summer 82%), when compared with a non-Asian population (OC 25 ) matched for age, sex, latitude and season. Summer sun exposure certainly contributes much to the fluctuations in annual 25,OHD 3 status in the UK, with higher values between June and October. In healthy middle-aged Danish women (enrolled in a 2·5 year period for the Danish Osteoporosis Prevention Study (Brot et al. 2001) ) there was a clear relationship between 25,OHD 3 levels and number of hours of sunshine per month with a lag period of 2 months. The prevalence of 25,OHD 3 deficiency in the Danish study was 7% rising to a maximum of 32·8% if sunshine was limited. Although this seasonal prevalence is normally seen in healthy subjects, recent concerns of a rising prevalence of wintertime 25,OHD 3 deficiency is now recognized in the white population (up to 78% of French male adolescents (Guillemant et al. 2001) , 27·8% healthy females from Southern Italy (Carnevale et al. 2001) ) and 62% of healthy non-pregnant women of child-bearing age in Jordan (Mishal 2001) . This deficient state can persist despite recommended vitamin D intakes . 25,OHD 3 deficiency was prevalent in our Asian group in both sexes despite the evident seasonal changes. Low 25,OHD 3 levels existed in the majority (90%) if defined as deficient by both OC 50 and OC 25 criteria compared with our non-Asian group. A recent study from Delhi has also found that excessive numbers of healthy Asian subjects of both sexes have low 25,OHD 3 concentrations whilst residing in abundant sunlight throughout the year (Goswami et al. 2000) . The extremely high prevalence of 25,OHD 3 deficiency perhaps suggests a genetic predisposition to 25,OHD 3 deficiency in Asians.
This suboptimal 25,OHD 3 status existing in Asians would facilitate the occurrence of symptomatic 25,OHD 3 deficiency particularly during increased requirements, such as in early childhood, adolescence, pregnancy and during lactation (Islam et al. 2002) .
Careful attention to maternal vitamin D status may also prevent infant morbidity and impact on a range of adult health outcomes (Hypponen et al. 2001 , Lamprecht & Lipkin 2001 . However, a Cochrane meta-analysis concluded that there is still insufficient evidence to supplement all mothers during pregnancy (Mahomed & Gulmezoglu 2000) . Most previous studies regarding use of maternal vitamin D supplementation are too diverse and do not provide the same summary statistic. As only two randomized controlled studies met strict criteria for the Cochrane analysis, the weight of evidence to decide on supplementation should currently be based on professional concern in specific populations or national guidance (Department of Health 1991). The most appropriate dose of vitamin D needed during pregnancy is yet to be defined as animal work has shown that exposure to extremely high amounts of vitamin D during gestation may result in adverse effects on foetal vasculature (Norman et al. 2002) . Given the high prevalence of 25,OHD 3 deficiency in Asian women, and the emerging evidence of early origins of adult disease, we would consider it both safe and prudent to provide at least the current recommended supplementation of vitamin D to all Asian women during pregnancy. The immediate and longer-term risks of 25,OHD 3 deficiency should be identified for all UK Asian families (Shaw & Pal 2002) .
Our data confirm that the prevalence of a 25,OHD 3 deficient state is high, particularly in UK Asians. 25,OHD 3 deficient levels should be standardized so that reports of prevalence can be compared. We would suggest that the distribution method provides an alternative statistical approach for clinicians when dealing with relatively small numbers (e.g. subgroup characteristics) for comparing either cross-sectional or longitudinal vitamin D data. The method is easy, the whole dataset can be used and an immediate visual description of the data can be generated. It is important to define and detect asymptomatic 25,OHD 3 deficiency early, as providing adequate vitamin D supplementation may prevent potential long-term consequences. analysis of all 25,OHD 3 assays and Mr A Bignall, Head of Biochemistry, City Hospital, Birmingham for his support of this study. We thank Medical Illustration and Graphics Department at Salford Royal Hospitals NHS Trust for reproduction of graphs. Frequency distributions a) Condense and summarize large amounts of data in a useful format b) Percentages are reported rather than raw counts to give readers more context c) Describe all variable types d) Facilitate graphic presentation of data e) Begin to identify population characteristics f) Permit comparison of data sets g) Cumulative frequency facilitates conversion into linear probits for probability analysis Probit Stands for probability unit Probit model Pr(y=1x)= (xb) Pr is the inverse of the cumulative standard normal distribution function, often referred as probit or normit and is the standard cumulative normal probability distribution and xb is the probit score (or index)
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